Considering that Sall4 depletion in mice minimally affects adult hematopoiesis [50], these separate works collectively suggest that the SALL4 regulation-targeted approaches, which induce leukemia apoptosis and differentiation but spare normal cells, likely represent clinically effective and novel anti-leukemia strategies. This evidence concerns the gene SALL4 and leukemia.